Allergic rhinoconjunctivitis.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
15 09 2020
Historique:
received: 22 07 2020
accepted: 22 07 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 29 6 2021
Statut: epublish

Résumé

Allergic rhinitis (AR) is induced by an IgE-mediated immune reaction after allergen exposure. The typical symptoms are itching, nasal discharge, sneezing and nasal obstruction. The diagnosis is based on the concordance between allergic symptoms and diagnostic tests. The skin prick test (SPT) is recommended as the "gold standard" method. First generation H1-antihistamines are widely used for treatment of AR. Intranasal glucocorticosteroids are well tolerated and can be used also in paediatric age. Allergic rhinitis cannot be considered as an isolated pathology. Other atopic diseases (allergic conjunctivitis, atopic eczema, asthma) are commonly associated.

Identifiants

pubmed: 33004777
doi: 10.23750/abm.v91i11-S.10310
pmc: PMC8023069
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2020007

Références

Ital J Pediatr. 2017 Jan 23;43(1):13
pubmed: 28257631
Curr Drug Metab. 2016;17(10):992-996
pubmed: 27890006
Curr Allergy Asthma Rep. 2009 Nov;9(6):460-4
pubmed: 19814919
Allergy. 2012 Jan;67(1):18-24
pubmed: 22050279
Ann Allergy Asthma Immunol. 2015 Feb;114(2):141-7
pubmed: 25624132
Allergy. 2018 Mar;73(3):673-682
pubmed: 29055045
Allergy. 2019 Sep;74(9):1611-1630
pubmed: 30887530
Int J Immunopathol Pharmacol. 2011 Oct;24(4 Suppl):25-8
pubmed: 22032783
Clin Exp Allergy. 2016 Jun;46(6):785-92
pubmed: 27009397
Expert Rev Clin Immunol. 2014 Oct;10(10):1337-47
pubmed: 25225773
Expert Opin Biol Ther. 2020 Jun;20(6):609-619
pubmed: 32053391
Allergy. 2019 Nov;74(11):2087-2102
pubmed: 30955224
Expert Opin Emerg Drugs. 2016;21(1):57-67
pubmed: 26733401
Antiinflamm Antiallergy Agents Med Chem. 2012;11(3):230-7
pubmed: 23173575
Expert Rev Clin Immunol. 2015;11(12):1321-33
pubmed: 26358006
Pediatr Allergy Immunol. 2016 Dec;27(8):795-803
pubmed: 27862336

Auteurs

Michele Miraglia Del Giudice (M)

Department of Woman, Child and of General and Specialized Surgery. University of Campania "Luigi Vanvitelli" Naples, Italy. michele.miraglia@unicampania.it.

Annalisa Allegorico (A)

epartment of Pediatrics, Bambino Gesù Children's Hospital, Rome, Italy. aallegorico@gmail.com.

Gian Luigi Marseglia (GL)

Pediatric Clinic Department of Pediatrics, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy. gl.marseglia@smatteo.pv.it.

Alberto Martelli (A)

Department of Pediatrics, G.Salvini Hospital, Garbagnate Milanese, Milan, Italy. agmartelli@asst-rhodense.it.

Mauro Calvani (M)

UOC di Pediatria. Azienda Ospedaliera S. Camillo Forlanini, Roma, Italy. maurocalvani58@gmail.com.

Fabio Cardinale (F)

Department of Pediatrics and Emergency, Pediatric Allergy and Pulmunology Unit, Azienda Ospedaliera-Universitaria Consorziale-Policlinico, Ospedale Pediatrico Giovanni XXIII, Bari, Italy.. fabiocardinale@libero.it.

Marzia Duse (M)

Department of Pediatrics, Sapienza University, Rome, Italy. marzia.duse@uniroma1.it.

Elena Chiappini (E)

Division of Paediatric Infectious Disease, Anna Meyer Children's University Hospital, Department of Health Sciences, University of Florence, Florence, Italy. elena.chiappini@unifi.it.

Sara Manti (S)

UOC Broncopneumologia Pediatrica e Fibrosi Cistica, AOUP "Vittorio-Emanuele", San Marco Hospital, Università di Catania, Catania, Italy. saramanti@hotmail.it.

Claudio Cravidi (C)

Agenzia Tutela della Salute, ATS (National Healthcare System), Pavia, Italy. claudiocravidi@gmail.com.

Maria Angela Tosca (MA)

Allergy Center, Department of Pediatrics, Istituto G. Gaslini, Genoa, Italy. mariangelatosca@gaslini.org.

Carlo Caffarelli (C)

Clinica Pediatrica, Dipartimento di Medicina e Chirurgia, Università di Parma, Italy. carlo.caffarelli@unipr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH